Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study to Determine Bioequivalence Between Two Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Healthy Male Subjects Under Fed Conditions

NCT07698288 is registered in ClinicalTrials.gov with ADIUM as lead sponsor.

NCT NCT07698288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study to Determine Bioequivalence Between Two Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Healthy Male Subjects Under Fed Conditions
Lead sponsor
ADIUM
Phase
Not applicable
Overall status
Completed
Start date
February 12, 2026
Completion date
April 16, 2026
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence